Harvard Bioscience, Inc. announced that its Board of Directors has elected Alan Edrick to Harvard Bioscience’s Board of Directors, effective September 3, 2019. Edrick, 51, has been the Executive Vice President and Chief Financial Officer of OSI Systems, Inc. Before joining OSI, Edrick served as the CFO of BioSource International, Inc., where he played a key role in the sale of the company to Invitrogen. Earlier in his career, he served as the CFO of North American Scientific, Inc., and worked at Price Waterhouse LLP in roles of increasing responsibility. With the addition of Edrick, Harvard Bioscience’s Board of Directors is comprised of 6 members, 5 of whom are independent.